Barclays
LFST icon

Barclays’s Lifestance Health LFST Stock Holding History

Barclays’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$369K – 5418
2024
Q4 		$369K Hold
50,000
– – ﹤0.01% 4006
2024
Q3 		$350K Hold
50,000
– – ﹤0.01% 3986
2024
Q2 		$246K Hold
50,000
– – ﹤0.01% 3466
2024
Q1 		$309K Buy
+50,000
New +$337K ﹤0.01% 3882

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Barclays's LFST Position: Q2 2026 in Review

Barclays reduced its Lifestance Health (LFST) stake by 26% in Q2 2026, selling an estimated $5.5M and leaving 2,054,414 shares worth $22M. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

Barclays first reported a position in LFST in Q1 2022 and has held it in 18 quarters since. The position peaked at $24.5M in Q4 2025. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Barclays held 2,054,414 shares of Lifestance Health worth $22M as of Q2 2026.
  • Barclays sold 711,278 Lifestance Health shares in Q2 2026, an estimated $5.5M.
  • Lifestance Health made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1081 holding.
  • Barclays first reported a position in Lifestance Health in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Lifestance Health position peaked at $24.5M in Q4 2025.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.